Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
Department of Health and Human Services
The purpose of this notice of funding opportunity (NOFO) is to support highly innovative mechanistic research to accelerate precision probiotic interventions. Specifically, this NOFO solicits R33 applications that will characterize person-specific features affecting probiotic responses to identify subgroups of probiotic responders and to enhance probiotic clinical outcomes. The ultimate goal of this NOFO is to identify, understand, and develop strategies to address barriers in precision probiotic therapies to account for the heterogenicity in humans that causes inconsistent probiotic responses. This NOFO will support studies to assess the ability of the unique patterns of host biology (e.g.,
Funding
Award size
Not specified
Type
Grant
Dates
Deadline
Later
Posted
10/31/2024
Closes
2027-06-02
Eligibility
Eligibility
Native American tribal governments (Federally recognized)Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher educationState governmentsNonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher educationIndependent school districtsPublic housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Private institutions of higher educationFor profit organizations other than small businessesOthers (see text field entitled "Additional Information on Eligibility" for clarification)County governmentsCity or township governmentsSpecial district governmentsSmall businessesPublic and State controlled institutions of higher education
Program
Funding area
Education - EDHealth - HL
Opportunity #
PAR-25-210
Source
Status
Open
Market
Government
Level
Federal
Source
Grants.gov